Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,037 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,037 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,037 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,037 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,037 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,037 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,037 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
6 Jan 2026
Shelly Wong SVP, Finance and CAO
Sold at will
$4.36K 3,925 at 1.11
4.3%
Not planned
6 Jan 2026
Stephen David Prior Chief Strategy Officer
Sold at will
$2.89K 2,858 at 1.01
4.6%
Not planned
6 Jan 2026
Kevin Patrick O'Brien Chief Financial Officer
Sold at will
$1.74K 1,150 at 1.51
8.0%
Not planned
5 Jan 2026
Sold at will
$9.03M 770,321 at 11.72
22.0%
Not planned
5 Jan 2026
Brian Lian President & CEO
Sold at will 4×
$7.69M 233,409 at 32.96
8.5%
Not planned
5 Jan 2026
James H Walter Co-Chief Executive Officer
Sold at will
$4.26M 310,003 at 13.74
17.3%
Not planned
5 Jan 2026
William M Hickey III Co-Chief Executive Officer
Sold at will
$4.26M 309,980 at 13.74
17.3%
Not planned
5 Jan 2026
Richard J Campo Chairman and CEO
Sold at will 2×
$4.17M 38,021 at 109.78
11.2%
Not planned
5 Jan 2026
Sanjay Beri CEO and Chairman
Sold at will
$3.05M 175,707 at 17.33
100%
Sold half or more
5 Jan 2026
Martin Cotter SVP, Vertical Business Units
Sold at will
$2.78M 10,000 at 278.45
16.8%
Not planned
5 Jan 2026
Patrick K. Craine CLAO and Corp Secretary
Sold at will
$2.29M 11,929 at 191.87
49.2%
Not planned
5 Jan 2026
Marianna Mancini Chief Operating Officer
Sold at will 4×
$1.90M 57,661 at 32.98
12.4%
Not planned
5 Jan 2026
Greg Zante Chief Financial Officer
Sold at will 4×
$1.90M 57,661 at 32.90
23.3%
Not planned
5 Jan 2026
Guy M Oliphint EVP, Chief Financial Officer
Sold at will
$1.77M 128,837 at 13.76
14.0%
Not planned
5 Jan 2026
Mark Munch Exec VP&Pres Bruker Nano Inc.
Sold at will 3×
$1.68M 33,843 at 49.66
20.9%
Not planned
5 Jan 2026
Todd S Thomson Director · indirect
Sold at will
$1.62M 280,000 at 5.80
23.6%
Not planned
5 Jan 2026
Sold at will
$1.51M 1,390 at 1,085.01
0.0%
Not planned
5 Jan 2026
Kenneth Galbraith Chair & CEO
Sold at will 2×
$1.36M 54,343 at 25.10
25.6%
Not planned
5 Jan 2026
James Fu Bin Lu 10% owner
Sold at will
$1.25M 92,071 at 13.53
18.0%
Not planned
5 Jan 2026
Gmt Capital Corp 10% owner
Sold at will
$1.15M 42,400 at 27.10
1.9%
Not planned
5 Jan 2026
Robert Regan Shannon EVP, Chief Accounting Officer
Sold at will
$966.70K 70,254 at 13.76
13.1%
Not planned
5 Jan 2026
John Charles Bell EVP, General Counsel
Sold at will
$966.63K 70,249 at 13.76
12.7%
Not planned
5 Jan 2026
Mckinsey Margaret Lyon (See remarks (4))
Sold at will
$864.56K 32,490 at 26.61
25.2%
Not planned
5 Jan 2026
Matto Andrew H Del Chief Financial Officer
Sold at will
$669.64K 38,616 at 17.34
48.2%
Not planned
5 Jan 2026
Daniel Faga President, CEO
Sold at will
$662.27K 15,309 at 43.26
3.2%
Not planned
5 Jan 2026
Alexander J. Jessett President & CFO
Sold at will
$617.24K 5,627 at 109.69
3.8%
Not planned
5 Jan 2026
Chi-Hong Ju Senior VP, Systems & GM, Asia
Sold at will
$584.11K 7,728 at 75.58
5.0%
Not planned
5 Jan 2026
John Kedzierski President & CEO
Sold at will
$522.48K 74,322 at 7.03
34.6%
Not planned
5 Jan 2026
Paul Andrew Moore Chief Scientific Officer
Sold at will 2×
$504.70K 20,110 at 25.10
39.2%
Not planned
5 Jan 2026
Roger E. Susi CEO, President, Chairman · indirect
Sold at will 5×
$488.42K 5,000 at 97.68
0.2%
Not planned
5 Jan 2026
Mark Casper EVP & Chief Legal Officer
Sold at will
$465.40K 5,000 at 93.08
20.5%
Not planned
5 Jan 2026
Thomas F DeBruine Chief Operating Officer
Sold at will
$448.58K 5,538 at 81.00
35.2%
Not planned
5 Jan 2026
David Kirk Whitney Chief Financial Officer
Sold at will
$373.76K 37,500 at 9.97
100%
Sold half or more
5 Jan 2026
Forager Fund, L.P. 10% owner
Sold at will
$353.87K 8,827 at 40.09
0.8%
Not planned
5 Jan 2026
Kang Jyh Lee Director
Sold at will
$339.00K 10,000 at 33.90
2.1%
Not planned
5 Jan 2026
Halim Dhanidina Director
Sold at will
$335.40K 6,000 at 55.90
31.3%
Not planned
5 Jan 2026
John M Leonard President and CEO
Sold at will
$314.48K 34,146 at 9.21
3.3%
Not planned
5 Jan 2026
Donald McClymont Chief Executive Officer
Sold at will 3×
$304.22K 82,957 at 3.67
30.8%
Not planned
5 Jan 2026
Sold at will
$295.33K 8,591 at 34.38
2.5%
Not planned
5 Jan 2026
Sold at will
$268.92K 10,148 at 26.50
34.4%
Not planned
5 Jan 2026
Jeffrey L Malmen Director
Sold at will
$268.17K 10,181 at 26.34
34.5%
Not planned
5 Jan 2026
Chris J Robison Director
Sold at will
$267.67K 10,201 at 26.24
10.3%
Not planned
5 Jan 2026
Jeffrey T L Smith EVP & Chief Medical Officer
Sold at will
$264.47K 10,538 at 25.10
36.5%
Not planned
5 Jan 2026
Sanjeev Aggarwal President and CEO
Sold at will
$259.03K 25,345 at 10.22
4.4%
Not planned
5 Jan 2026
Sold at will
$244.06K 2,225 at 109.69
7.1%
Not planned
5 Jan 2026
Sold at will
$230.79K 2,104 at 109.69
17.1%
Not planned
5 Jan 2026
Elena Gomez President, CFO
Sold at will
$229.36K 6,672 at 34.38
4.0%
Not planned
5 Jan 2026
Evangelos Perros Chief Financial Officer
Sold at will
$224.15K 9,750 at 22.99
8.9%
Not planned
5 Jan 2026
Paul F. Lizzul Chief Medical Officer
Sold at will
$182.51K 4,219 at 43.26
11.2%
Not planned
5 Jan 2026
Sold at will
$176.26K 24,907 at 7.08
0.9%
Not planned
Showing 19,001–19,050 of 23,037. ← Newer Page 381 of 461 Older →